Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Wilhelm

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Ophthalmic Surgery, Lasers & Imaging Retina|December 19, 2017
Optical Coherence Tomography in Patients With the Subretinal Implant Retina Implant Alpha IMSLaura Kuehlewein, Veronique Kitiratschky, Mariya Gosheva, et al.
The British Journal of Ophthalmology|May 19, 2021
Three-year results of phase I retinal gene therapy trial for CNGA3-mutated achromatopsia: results of a non randomised controlled trialFelix Friedrich Reichel, Stylianos Michalakis, Barbara Wilhelm, et al.
The British Journal of Ophthalmology|August 18, 2025
Safety and vision outcomes of subretinal gene supplementation therapy in <i>PDE6A</i>-associated retinitis pigmentosa: a non-randomised controlled trialFelix F Reichel, M Dominik Fischer, Katarina Stingl, et al.
Ophthalmic Research|November 28, 2019
Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa: A Multicenter Safety Study of the OkuStim® System (TESOLA-Study)Jasleen K Jolly, Siegfried K Wagner, Peter Martus, et al.
Vision Research|March 28, 2015
Subretinal Visual Implant Alpha IMS--Clinical trial interim reportKatarina Stingl, Karl Ulrich Bartz-Schmidt, Dorothea Besch, et al.
JAMA Ophthalmology|May 1, 2020
Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled TrialM Dominik Fischer, Stylianos Michalakis, Barbara Wilhelm, et al.
JAMA Ophthalmology|October 15, 2020
Clinical Phenotype and Course of PDE6A-Associated Retinitis Pigmentosa Disease, Characterized in Preparation for a Gene Supplementation TrialLaura Kuehlewein, Ditta Zobor, Sten Olof Andreasson, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Ophthalmic Surgery, Lasers & Imaging Retina|December 19, 2017
Optical Coherence Tomography in Patients With the Subretinal Implant Retina Implant Alpha IMSLaura Kuehlewein, Veronique Kitiratschky, Mariya Gosheva, et al.
The British Journal of Ophthalmology|May 19, 2021
Three-year results of phase I retinal gene therapy trial for CNGA3-mutated achromatopsia: results of a non randomised controlled trialFelix Friedrich Reichel, Stylianos Michalakis, Barbara Wilhelm, et al.
The British Journal of Ophthalmology|August 18, 2025
Safety and vision outcomes of subretinal gene supplementation therapy in <i>PDE6A</i>-associated retinitis pigmentosa: a non-randomised controlled trialFelix F Reichel, M Dominik Fischer, Katarina Stingl, et al.
Ophthalmic Research|November 28, 2019
Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa: A Multicenter Safety Study of the OkuStim® System (TESOLA-Study)Jasleen K Jolly, Siegfried K Wagner, Peter Martus, et al.
Vision Research|March 28, 2015
Subretinal Visual Implant Alpha IMS--Clinical trial interim reportKatarina Stingl, Karl Ulrich Bartz-Schmidt, Dorothea Besch, et al.
JAMA Ophthalmology|May 1, 2020
Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled TrialM Dominik Fischer, Stylianos Michalakis, Barbara Wilhelm, et al.
JAMA Ophthalmology|October 15, 2020
Clinical Phenotype and Course of PDE6A-Associated Retinitis Pigmentosa Disease, Characterized in Preparation for a Gene Supplementation TrialLaura Kuehlewein, Ditta Zobor, Sten Olof Andreasson, et al.
Pageof 11